From the blog

UK Pharmaceutical Company’s Potential Cancer Vaccine Assists in Treating Mesothelioma

Combination treatment therapies are common for those suffering from mesothelioma because the aggressive nature of this asbestos-caused disease makes it difficult to treat effectively.  Ongoing developments and advancements in medicine have also helped mesothelioma patients extend their life and manage pain throughout the years. While there is no cure for[…]

Read More »

Determining the Exposure Limit for Asbestos

The Occupational Safety and Health Administration (OSHA) has maintained that “there is no ‘safe’ level of asbestos exposure for any type of asbestos fiber,” but despite these warnings, asbestos is still legal and still used in the United States.  Different government agencies have their own rules and regulations for asbestos[…]

Read More »

Funding Needed for Lung Cancer Awareness and Research – How You Can Help

For a cancer than claims more lives than breast, colon, and prostate cancer combined, Lung Cancer is severely underfunded, leaving scientists and researchers reliant on private funding and donations. Funding for lung cancer, as with many other cancers, plays a critical role in developing and investigating research that could eventually[…]

Read More »

Dealing With a Mesothelioma Diagnosis

A mesothelioma diagnosis is devastating for those suffering with the disease and family members alike. The nature of the illness is aggressive, and there is currently no cure. The quality of life for a mesothelioma patient can decrease significantly and quickly as the cancer spreads throughout the body. One of[…]

Read More »

Quality of Life After Pleurectomy/Decortication vs. Extra Pleural Pneumonectomy

On the rare instance that mesothelioma is diagnosed in the early stages of the disease, patients have the option for surgery.  There are several surgical procedures used to treat mesothelioma. Some mesothelioma surgeries aim to provide a curative effect, while others are performed for palliative purposes. Pleurectomy/decortication (P/D) and extra[…]

Read More »

Phase 1 Clinical Trial For Those With Peritoneal Mesothelioma Underway

Mesothelioma is a rare cancer affecting only about 3,000 Americans each year. Most of those diagnosed are diagnosed with pleural mesothelioma, but a small number (approx. 500 per year) are diagnosed with peritoneal mesothelioma, which is mesothelioma in the abdominal lining. With so few diagnosed with peritoneal mesothelioma, studying and[…]

Read More »

Decade Long Study Reveals Potential for Early Detection in Mesothelioma

For many patients who are suffering from malignant mesothelioma, their diagnosis came quickly after experiencing symptoms. In many cases, this is because symptoms of mesothelioma typically do not appear until the cancer has fully developed and it’s in the later stages. For those suffering from pleural mesothelioma – the most[…]

Read More »

Researchers Theorize Drug from the 1800s Could Improve Radiation Treatments in Mesothelioma Patients

Radiation therapy for those suffering from mesothelioma is not typically the first line of treatment because of its overall effectiveness. High-energy x-rays, gamma rays, and neutrons that make up radiation treatment aim to shrink tumors and ultimately kill cancer cells, but since mesothelioma tumors often have an irregular shape, it[…]

Read More »

Phase III Clinical Trial for Nintedanib Discontinued After Yielding Negative Results

Disappointing results from the LUME-Phase III clinical trial regarding nintedanib is a setback for scientists and researchers who were hopeful they were on the brink of finding a new, first line treatment for those suffering from mesothelioma. Results from the Phase II clinical trial – published earlier this year –[…]

Read More »